Evaluation of Telemedicine Use Among US Patients With Newly Diagnosed Cancer by Socioeconomic Status
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
The COVID-19 pandemic led to a decline of in-person clinical visits. Telemedicine increased during this time, but there was lower uptake in high-poverty areas. For patients newly diagnosed with cancer, a delay in care could cause irreversible harm; therefore these patients may be especially motivated to use telemedicine to keep health care appointments during the pandemic. The present study uses data from a large commercial insurer to examine the uptake of telemedicine visits among patients with newly diagnosed cancer, with a specific focus on assessing differential uptake by socioeconomic status (SES).
JAMA Oncology , résumé, 2020